MJP
Michael J. Puzo Portfolio holdings
AUM
$351M
This Quarter Return
+2.66%
1 Year Return
+12.34%
3 Year Return
+65.3%
5 Year Return
+106.55%
10 Year Return
+254.06%
AUM
$236M
AUM Growth
+$236M
(+0.61%)
Cap. Flow
-$2.83M
Cap. Flow
% of AUM
-1.2%
Top 10 Holdings %
Top 10 Hldgs %
39.01%
Holding
79
New
–
Increased
18
Reduced
52
Closed
2
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$547K |
| 2 |
Illumina
ILMN
|
$330K |
| 3 |
3M
MMM
|
$255K |
| 4 |
Fortive
FTV
|
$240K |
| 5 |
Gilead Sciences
GILD
|
$227K |
Top Sells
| 1 |
Mastercard
MA
|
$439K |
| 2 |
Johnson & Johnson
JNJ
|
$408K |
| 3 |
GE Aerospace
GE
|
$388K |
| 4 |
Oracle
ORCL
|
$372K |
| 5 |
Intel
INTC
|
$336K |
Sector Composition
| 1 | Technology | 23.57% |
| 2 | Healthcare | 22.93% |
| 3 | Industrials | 14.15% |
| 4 | Financials | 10.16% |
| 5 | Consumer Staples | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bank OZK
OZK
$5.9B
| $2.99M | 1.27% |
66,430
-3,025
| -4% | -$136K |
|
27
EOG Resources
EOG
$68.8B
| $2.99M | 1.26% |
23,998
+813
| +4% | +$101K |
|
|
28
Illumina
ILMN
$15.5B
| $2.83M | 1.2% |
10,123
+1,183
| +13% | +$330K |
|
29
Xylem
XYL
$34.2B
| $2.56M | 1.08% |
37,910
-2,300
| -6% | -$155K |
|
|
30
Oracle
ORCL
$633B
| $2.52M | 1.07% |
57,226
-8,450
| -13% | -$372K |
|
31
PepsiCo
PEP
$206B
| $2.48M | 1.05% |
22,787
-199
| -0.9% | -$21.6K |
|
32
Merck
MRK
$214B
| $1.81M | 0.77% |
29,902
-800
| -3% | -$48.5K |
|
33
AbbVie
ABBV
$374B
| $1.64M | 0.69% |
17,676
-900
| -5% | -$83.4K |
|
|
34
Fortive
FTV
$16B
| $1.56M | 0.66% |
20,233
+3,108
| +18% | +$240K |
|
|
35
Gilead Sciences
GILD
$140B
| $1.49M | 0.63% |
20,998
+3,202
| +18% | +$227K |
|
36
Emerson Electric
EMR
$73.9B
| $1.37M | 0.58% |
19,814
-912
| -4% | -$63K |
|
37
McCormick & Company Non-Voting
MKC
$18.5B
| $1.37M | 0.58% |
11,770
+70
| +0.6% | +$8.12K |
|
|
CELG
38
DELISTED
Celgene Corp
CELG
| $1.35M | 0.57% |
16,973
+6,883
| +68% | +$547K |
|
39
Empire State Realty Series ES
ESBA
$2.02B
| $1.34M | 0.57% |
78,573
-4,000
| -5% | -$68.4K |
|
40
J.M. Smucker
SJM
$11.7B
| $1.32M | 0.56% |
12,237
-500
| -4% | -$53.8K |
|
41
Visa
V
$679B
| $1.29M | 0.55% |
9,740
-640
| -6% | -$84.7K |
|
|
RDS.A
42
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.12M | 0.47% |
16,100
| – | – |
|
43
Vanguard Total Stock Market ETF
VTI
$522B
| $913K | 0.39% |
6,500
-200
| -3% | -$28.1K |
|
44
Berkshire Hathaway Class B
BRK.B
$1.08T
| $905K | 0.38% |
4,850
-300
| -6% | -$56K |
|
45
Schlumberger
SLB
$53.6B
| $870K | 0.37% |
12,964
+661
| +5% | +$44.4K |
|
46
Bristol-Myers Squibb
BMY
$96.5B
| $828K | 0.35% |
14,960
-1,640
| -10% | -$90.8K |
|
47
Union Pacific
UNP
$132B
| $788K | 0.33% |
5,558
-42
| -0.8% | -$5.96K |
|
48
Colgate-Palmolive
CL
$68.2B
| $718K | 0.3% |
11,072
-50
| -0.4% | -$3.24K |
|
49
State Street
STT
$32.1B
| $628K | 0.27% |
6,749
-800
| -11% | -$74.4K |
|
50
Pfizer
PFE
$142B
| $595K | 0.25% |
16,388
-675
| -4% | -$24.5K |
|